Hemophilia A differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Hemophilia A]] must be differentiated from other diseases that cause abnormal or excessive bleeding.<ref> Konkle BA, Josephson NC, Nakaya Fletcher S. Hemophilia A. 2000 Sep 21 [Updated 2014 Jun 5]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www-ncbi-nlm-nih-gov.laneproxy.stanford.edu/books/NBK1404/ </ref> | [[Hemophilia A]] must be differentiated from other diseases that cause abnormal or excessive bleeding.<ref>Konkle BA, Josephson NC, Nakaya Fletcher S. Hemophilia A. 2000 Sep 21 [Updated 2014 Jun 5]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www-ncbi-nlm-nih-gov.laneproxy.stanford.edu/books/NBK1404/ </ref> | ||
==Differentiating Hemophilia A from other Diseases== | ==Differentiating Hemophilia A from other Diseases== | ||
Line 26: | Line 26: | ||
! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Joint Bleeding | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gastrointestinal bleeding | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Skin Bruises | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="1" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CBC | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PT | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |PTT | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BT | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Factor VIII | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Factor IX | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fibrinogen | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |U/A | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |S/E | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemophilia A | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>+</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>+</big>''' | ||
Line 56: | Line 56: | ||
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemophilia B | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | ||
Line 74: | Line 74: | ||
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
! style="background: #F5F5F5; padding: 5px; text-align: center;" | | ! style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[ | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[von Willebrand disease]] | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | ||
Line 92: | Line 92: | ||
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Vitamin K deficiency | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | ||
Line 111: | Line 110: | ||
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↓</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Warfarin Toxicity | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>+</big>''' | ||
Line 129: | Line 128: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓↓/</big>N''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>↓↓/</big>N''' | ||
! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ! style="background: #F5F5F5; padding: 5px; text-align: center;" |N | ||
! style="background: #F5F5F5; padding: 5px; text-align: center;" | | ! style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
! style="background: #F5F5F5; padding: 5px; text-align: center;" | | ! style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Platelets disorders | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>+</big>''' | ||
Line 147: | Line 146: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↑/</big>N''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↑/</big>N''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | <big>'''↑'''</big> | | style="background: #F5F5F5; padding: 5px; text-align: center;" | <big>'''↑'''</big> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Liver Failure | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" |'''<big>-/+</big>''' | ||
Line 165: | Line 164: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↑/</big>N''' | | style="background: #F5F5F5; padding: 5px; text-align: center;" | '''<big>↑/</big>N''' | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | <big>'''↑'''</big> | | style="background: #F5F5F5; padding: 5px; text-align: center;" | <big>'''↑'''</big> | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" | | ||
|} | |} | ||
Revision as of 04:48, 14 July 2018
Hemophilia A Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hemophilia A differential diagnosis On the Web |
American Roentgen Ray Society Images of Hemophilia A differential diagnosis |
Risk calculators and risk factors for Hemophilia A differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fahd Yunus, M.D. [2]
Overview
Hemophilia A must be differentiated from other diseases that cause abnormal or excessive bleeding.[1]
Differentiating Hemophilia A from other Diseases
The most important differential diagnosis is that of hemophilia B (also known as Christmas disease) or von Willebrand disease. The former is usually considered if factor VIII levels are normal in a person with a hemophilia phenotype. The latter is excluded on routine testing for that condition.
Differential Diagnosis
Other diseases which should be considered in the differential include:
- Warfarin toxicity
- Liver disease
- Vitamin K deficiency
Diseases | Clinical manifestations | Para-clinical findings | Additional findings | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | |||||||||||||||
Lab Findings | ||||||||||||||||
Joint Bleeding | Gastrointestinal bleeding | Skin Bruises | CBC | PT | PTT | BT | Factor VIII | Factor IX | Fibrinogen | U/A | S/E | |||||
Hemophilia A | + | + | + | ↓/N | - | ↓ | + | + | ↓ | ↓/N | ↓/N | N | ↓ | |||
Hemophilia B | - | -/+ | -/+ | N | - | ↓/N | - | - | N | N | ↓/N | N | ↓ | |||
von Willebrand disease | - | -/+ | -/+ | N | - | ↓↓/N | - | - | N | N | ↓/N | N | ↓ | |||
Vitamin K deficiency | - | -/+ | -/+ | N | - | N | - | - | N | ↓ ↓ | ↑ ↑ | N | ↓ | |||
Warfarin Toxicity | -/+ | + | - | ↑/N | + | ↓ | + | - | N | ↓/N | N | ↓↓/N | N | |||
Platelets disorders | - | + | -/+ | ↓ | - | N | - | - | ↓ | ↓/N | ↓ | ↑/N | ↑ | |||
Liver Failure | -/+ | -/+ | ↓ | - | ↓ | - | - | ↓ | ↓/N | ↓ | ↑/N | ↑ |
References
- ↑ Konkle BA, Josephson NC, Nakaya Fletcher S. Hemophilia A. 2000 Sep 21 [Updated 2014 Jun 5]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. Available from: http://www-ncbi-nlm-nih-gov.laneproxy.stanford.edu/books/NBK1404/